Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions

Vanessa Alende-Castro, Manuela Alonso-Sampedro, Carmen Fernández-Merino, Juan Sánchez-Castro, Bernardo Sopeña, Francisco Gude and Arturo Gonzalez-Quintela
The Journal of the American Board of Family Medicine September 2021, 34 (5) 974-983; DOI: https://doi.org/10.3122/jabfm.2021.05.210072
Vanessa Alende-Castro
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Alonso-Sampedro
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
BSc, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Fernández-Merino
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Sánchez-Castro
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernardo Sopeña
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Gude
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arturo Gonzalez-Quintela
From the Department of Internal Medicine, Complejo Hospitalario Universitario, University of Santiago de Compostela, Spain (VA-C, BS, AG-Q); Primary Care Center, A Estrada, Spain (CF-M, JS-C); Department of Clinical Epidemiology, Complejo Hospitalario Universitario, Santiago de Compostela, Spain (MA-S, FG).
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Boxplot of serum C-reactive protein concentrations in relation to the number of metabolic syndrome criteria. Outliers (values outside 1.5 times the interquartile range above the upper quartile and below the lower quartile) are not represented but are included in the analyses. P value was obtained with the Jonckheere-Terpstra trend test.

Tables

  • Figures
    • View popup
    Table 1.

    C-Reactive Protein Concentrations According to Demographics, Lifestyle Factors, and Metabolic Abnormalities*

    FactorNCRP (mg/dL)P value
    Sex
        Female8300.14 (0.04–0.42)Reference
        Male6690.13 (0.04–0.33).186
    Age (years)
        18–352950.09 (0.03–0.33)Reference
        >35–504080.11 (0.04–0.35).033
        >50–653880.17 (0.06–0.39)<.001
        >654080.18 (0.06–0.47)<.001
    Alcohol consumption
        Abstainers5390.16 (0.05–0.46)Reference
        Light drinkers5910.11 (0.03–0.33)<.001
        Moderate drinkers2390.15 (0.04–0.37).146
        Heavy drinkers1300.17 (0.08–0.43).363
    Smoking
        Never smokers8200.15 (0.05–0.41)Reference
        Ex-smokers3880.13 (0.04–0.34).127
        Current smokers2910.13 (0.04–0.36).183
    Physical activity
        Low5830.16 (0.05–0.46)Reference
        Moderate5480.14 (0.04–0.36).017
        High3680.11 (0.04–0.33).005
    Body mass index
        Normal weight4210.06 (0.02–0.17)Reference
        Overweight5670.13 (0.05–0.36)<.001
        Obesity5110.25 (0.10–0.55)<.001
    Metabolic syndrome
        No11910.11 (0.04–0.33)Reference
        Yes3080.27 (0.12–0.59)<.001
    • CRP, C-reactive protein.

    • ↵* Data are medians and interquartile (25th–75th percentile) ranges (in brackets). The normal range for serum CRP concentrations is 0–0.5 mg/dL (0–5 mg/L).

    • View popup
    Table 2.

    Multivariate Analysis. Linear Regression of C-Reactive Protein (log10-Transformed) in Relation to Demographics, Lifestyle Factors, and Metabolic Factors

    FactorCoefficient (SE)P value
    Sex (male)
        FemaleReferenceNA
        Male−0.050 (0.035).157
    Age (years)0.002 (0.001).087
    Alcohol consumption
        AbstainersReferenceNA
        Light drinkers−0.114 (0.036).001
        Moderate drinkers−0.090 (0.048).061
        Heavy drinkers0.013 (0.062).829
    Smoking
        Never smokersReferenceNA
        Ex-smokers−0.029 (0.038).445
        Current smokers0.087 (0.043).042
    Physical activity
        LowReferenceNA
        Moderate−0.033 (0.035).348
        High−0.014 (0.040).725
    Body mass index (kg/m2)0.045 (0.003)<.001
    Metabolic syndrome
        NoReferenceNA
        Yes0.073 (0.042).084
    Constant (intercept)−2.178 (0.107)NA
    • CRP, C-reactive protein; NA, not applicable; SE, standard error.

    • * For the logarithmic transformation, we attributed an arbitrary value of 0.001 mg/dL to patients with undetectable CRP (n = 4).

    • † All listed covariates were entered into the equation.

    • ‡ Covariates explained 17.4% of the CRP variability (R2, 0.174). The body mass index explained 15.7% of the CRP variability.

    • View popup
    Table 3.

    Comparison of Demographics, Lifestyle Factors, Metabolic Abnormalities among Categories of Agreement and Discordance between C-Reactive Protein and Erythrocyte Sedimentation Rate Values

    FactorNormal CRP Normal ESR (n = 1123)High ESR Normal CRP (n = 72)High CRP Normal ESR (n = 208)High CRP High ESR (n = 69)
    Sex (male)II514 (45.8)30 (41.7)78 (37.5)*33 (47.8)
    Age (years)¶50 (37–65)64 (55–74)‡55 (42–67)†64 (49–76)‡
    Alcohol consumption (g/week)¶30 (3–130)20 (3–85)10 (3–90)*13 (3–140)
    Smoking (current)II223 (19.9)12 (16.7)36 (17.3)11 (15.9)
    Physical activity (low)II411 (36.6)31 (43.1)91 (43.8)40 (58.0)‡
    Body mass index (kg/m2)¶27.2 (23.9–30.6)28.1 (25.4–31.7)*30.0 (26.2–33.7)‡32.0 (27.0–35.6)‡
    Metabolic syndrome (yes)II185 (16.5)24 (33.3)‡68 (32.7)‡23 (33.3)‡
    Serum IL-6 (pg/mL)¶<2 (<2–3.0)2.2 (<2–4.1)3.0 (<2–4.9)‡4.7 (2.3–8.7)‡
    • CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.

    • ↵* P < .05;

    • ↵† P < .01; and

    • ↵‡ P < .001 compared with the reference category (individuals with normal CRP and normal ESR).

    • fData available for 1472 individuals.

    • § High CRP is defined as >0.5 mg/dL (>5 mg/L); high ESR is defined as >20 mm/h for men and >30 mm/h for women.

    • ↵II Figures for sex, smoking, physical activity, and metabolic syndrome are absolute numbers and percentages (within parentheses).

    • ↵¶ Figures for age, alcohol consumption, body mass index, and serum IL-6 are medians and interquartile ranges (within parentheses).

    • View popup
    Table 4.

    Multivariate Analysis (Logistic Regression) of Factors Associated with Discordance between C-Reactive Protein and Erythrocyte Sedimentation Rate*,†

    High ESR and normal CRP (n = 72)High CRP and normal ESR (n = 208)
    FactorOR (95% CI)P valueOR (95% CI)P value
    Sex (male)0.815 (0.448–1.481).5020.699 (0.483–1.012).058
    Age (years)1.052 (1.034–1.071)<.0010.998 (0.988–1.008).695
    Body mass index (kg/m2)0.986 (0.930–1.045).6331.099 (1.064–1.136)<.001
    • CI, confidence interval; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; OR, odds ratio.

    • ↵* High CRP is defined as >0.5 mg/dL (>5 mg/L); high ESR is defined as >20 mm/h for men and >30 mm/h for women.

    • ↵† A total of 1472 cases were entered into the equations. The odds ratio (adjusted for all listed variables and alcohol consumption, smoking, metabolic syndrome, and physical activity).

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family   Medicine: 34 (5)
The Journal of the American Board of Family Medicine
Vol. 34, Issue 5
September/October 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions
Vanessa Alende-Castro, Manuela Alonso-Sampedro, Carmen Fernández-Merino, Juan Sánchez-Castro, Bernardo Sopeña, Francisco Gude, Arturo Gonzalez-Quintela
The Journal of the American Board of Family Medicine Sep 2021, 34 (5) 974-983; DOI: 10.3122/jabfm.2021.05.210072

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions
Vanessa Alende-Castro, Manuela Alonso-Sampedro, Carmen Fernández-Merino, Juan Sánchez-Castro, Bernardo Sopeña, Francisco Gude, Arturo Gonzalez-Quintela
The Journal of the American Board of Family Medicine Sep 2021, 34 (5) 974-983; DOI: 10.3122/jabfm.2021.05.210072
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Re: C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions
  • Response: Re: C-Reactive Protein versus Erythrocyte Sedimentation Rate: Implications Among Patients with No Known Inflammatory Conditions
  • Practical Clinical Topics, Digging Deeper into COVID-19, Social Determinants of Health, and Equity
  • Google Scholar

More in this TOC Section

  • Successful Implementation of Integrated Behavioral Health
  • Identifying and Addressing Social Determinants of Health with an Electronic Health Record
  • Integrating Adverse Childhood Experiences and Social Risks Screening in Adult Primary Care
Show more Original Research

Similar Articles

Keywords

  • Age
  • Alcohol
  • Body Mass Index
  • C-Reactive Protein
  • Erythrocyte Sedimentation Rate
  • Inflammatory Disorders
  • Interleukin-6
  • Metabolic Syndrome
  • Obesity
  • Physical Exercise
  • Sex
  • Smoking

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire